{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:22:15Z","timestamp":1696465335224},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,12,18]],"date-time":"2009-12-18T00:00:00Z","timestamp":1261094400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1007\/s00296-009-1281-0","type":"journal-article","created":{"date-parts":[[2009,12,17]],"date-time":"2009-12-17T06:13:21Z","timestamp":1261030401000},"page":"241-244","source":"Crossref","is-referenced-by-count":4,"title":["A case of cellulitis causing tissue defect during etanercept therapy"],"prefix":"10.1007","volume":"32","author":[{"given":"Dulgeroglu","family":"Deniz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umay","family":"Ebru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bal","family":"Ajda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetik Menevse","family":"Gulsum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatlican","family":"Semih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cakci","family":"Aytul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,12,18]]},"reference":[{"key":"1281_CR1","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJM200003163421110","volume":"342","author":"DS Pisetsky","year":"2000","unstructured":"Pisetsky DS (2000) Tumor necrosis factor blockers in rheumatoid arthritis. N Eng J Med 342:810\u2013811","journal-title":"N Eng J Med"},{"key":"1281_CR2","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2133.2007.07682.x","volume":"156","author":"HH Lee","year":"2007","unstructured":"Lee HH, Song IH, Friedrich M et al (2007) Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-\u03b1 antagonists. Br J Dermatol 156:486\u2013491","journal-title":"Br J Dermatol"},{"key":"1281_CR3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJM199707173370301","volume":"337","author":"LW Moreland","year":"1997","unstructured":"Moreland LW, Baumgartner SW, Schiff MH et al (1997) Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p-75)-Fc fusion protein. N Eng J Med 337:141\u2013147","journal-title":"N Eng J Med"},{"issue":"5","key":"1281_CR4","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/09546630410017275","volume":"15","author":"NA Scheinfeld","year":"2004","unstructured":"Scheinfeld NA (2004) Comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers etanercept, infliximab and adalimumab. J Dermatol Treat 15(5):280\u2013294","journal-title":"J Dermatol Treat"},{"key":"1281_CR5","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1056\/NEJM200011303432201","volume":"343","author":"JM Bathon","year":"2000","unstructured":"Bathon JM, Martin RW, Fleischmann RM et al (2000) A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 343:1586\u20131593","journal-title":"N Engl J Med"},{"key":"1281_CR6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/rheumatology\/41.1.116","volume":"41","author":"ME McCain","year":"2002","unstructured":"McCain ME, Quinet RJ, Davis WE (2002) Etanercept and infliximab associated with cutaneous vasculitis. Rheumatology 41:116\u2013117","journal-title":"Rheumatology"},{"key":"1281_CR7","doi-asserted-by":"crossref","unstructured":"Bleumink GS, ter Borg EJ, Ramselaar CG, Stricker BH Ch (2001) Etanercept induced subacute cutaneous lupus erythematosus. Rheumatology 40:1317\u20131319","DOI":"10.1093\/rheumatology\/40.11.1317"},{"key":"1281_CR8","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1136\/ard.61.9.850","volume":"61","author":"F Soliotis","year":"2002","unstructured":"Soliotis F, Glover M, Jawad ASM (2002) Severe skin reaction after leflunomide and etanercept in a patient with rheumatoid arthritis. Ann Rheum Dis 61:850\u2013851","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"1281_CR9","doi-asserted-by":"crossref","first-page":"634","DOI":"10.7326\/0003-4819-131-8-199910190-00031","volume":"131","author":"PH Brion","year":"1999","unstructured":"Brion PH, Mittal-Henkle A, Kalunian KC (1999) Autoimmune skin rashes associated with etanercept for rheumatoid arthritis. Ann Intern Med 131(8):634","journal-title":"Ann Intern Med"},{"key":"1281_CR10","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2133.2006.07598.x","volume":"156","author":"Y Gilaberte","year":"2007","unstructured":"Gilaberte Y, Coscojuela C, Vazquez C, Rosello R, Vera J (2007) Perforating folliculitis associated with tumor necrosis factor-\u03b1 inhibitors administered for rheumatoid arthritis. Br J Dermatol 156:368\u2013371","journal-title":"Br J Dermatol"},{"key":"1281_CR11","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s10067-004-0950-3","volume":"23","author":"JC Gerster","year":"2004","unstructured":"Gerster JC, Dudler J (2004) Cellulitis caused by Capnocytophaga cynodegmi associated with etanercept treatment in a patient with rheumatoid arthritis. Clin Rheumatol 23:570\u2013571","journal-title":"Clin Rheumatol"},{"key":"1281_CR12","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.4049\/jimmunol.168.9.4620","volume":"168","author":"DR Roach","year":"2002","unstructured":"Roach DR, Bean AG, Demangel C, France MP, Briscoe H, Britton WJ (2002) TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol 168:4620\u20134627","journal-title":"J Immunol"},{"key":"1281_CR13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.semarthrit.2006.02.001","volume":"36","author":"DE Furst","year":"2006","unstructured":"Furst DE, Wallis R, Broder M, Beenhouwer DO (2006) Tumor necrosis factor antagonists: different kinetics and\/or mechanisms of action may explain differences in the risk for developing granulomatous infection. Semin Arthritis Rheum 36:159\u2013167","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"1281_CR14","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1093\/rheumatology\/kem033","volume":"46","author":"MH Weisman","year":"2007","unstructured":"Weisman MH, Paulus HE, Burch FX et al (2007) A placebo-controlled, randomized, double-blinded study evaluating the safety of etanercept in patients with rheumatoid arthritis and concomitant comorbid diseases. Rheumatology 46(7):1122\u20131125","journal-title":"Rheumatology"},{"key":"1281_CR15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1056\/NEJM199901283400401","volume":"340","author":"ME Weinblatt","year":"1999","unstructured":"Weinblatt ME, Kremer JM, Bankhurst AD et al (1999) A trial of etanercept, a recombinant tumour necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Eng J Med 340:253\u2013259","journal-title":"N Eng J Med"},{"key":"1281_CR16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jaad.2005.11.1101","volume":"57","author":"JA Dyer","year":"2007","unstructured":"Dyer JA, Guitard J, Gitelman MK, Mancini AJ (2007) Neutrophilic panniculitis in infancy: a cutaneous manifestation of juvenile rheumatoid arthritis. J Am Acad Dermatol 57:65\u201368","journal-title":"J Am Acad Dermatol"},{"key":"1281_CR17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.sder.2007.02.001","volume":"26","author":"L Requena","year":"2007","unstructured":"Requena L (2007) Normal subcutaneous fat, necrosis of adipocytes and classification of the panniculitides. Semin Cutan Med Surg 26:66\u201370","journal-title":"Semin Cutan Med Surg"},{"key":"1281_CR18","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.det.2008.05.005","volume":"26","author":"YD Jimenez","year":"2008","unstructured":"Jimenez YD, Fraga J, Diez AG (2008) Infective panniculitis. Dermatol Clin 26:471\u2013480","journal-title":"Dermatol Clin"},{"key":"1281_CR19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1067\/mjd.2001.114736","volume":"45","author":"L Requena","year":"2001","unstructured":"Requena L, Yus ES (2001) Panniculitis. Part I: mostly septal panniculitis. J Am Acad Dermatol 45:163\u2013183","journal-title":"J Am Acad Dermatol"},{"key":"1281_CR20","first-page":"323","volume":"68","author":"AJ Headley","year":"2003","unstructured":"Headley AJ (2003) Necrotizing soft tissue infections: a primary care review. Am Fam Physician 68:323\u2013328","journal-title":"Am Fam Physician"},{"issue":"3","key":"1281_CR21","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1186\/ar1724","volume":"7","author":"M Flendrie","year":"2005","unstructured":"Flendrie M, Vissers WHPM, Creemers MCW, de Jong EMGJ, van de Kerkhof PCM, van Riel PLCM (2005) Dermatological conditions during TNF-\u03b1 blocking therapy in patients with rheumatoid arthritis: a prospective study. Arthritis Res Ther 7(3):666\u2013676","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"1281_CR22","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00296-008-0695-4","volume":"29","author":"KH Choi","year":"2009","unstructured":"Choi KH, Yoo WH (2009) Necrotizing fasciitis in a patient treated with etanercept for dermatomyositis. Rheumatol Int 29(4):463\u2013466","journal-title":"Rheumatol Int"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-009-1281-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-009-1281-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-009-1281-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T07:18:38Z","timestamp":1559027918000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-009-1281-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,18]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["1281"],"URL":"https:\/\/doi.org\/10.1007\/s00296-009-1281-0","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,18]]}}}